Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutation

ABSTRACT: Interventions: SOX+BEV and IRIS+BEV sequential therapy Primary outcome(s): Second progression free survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2630227 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR